LOOMIS SAYLES & CO L P - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$81,314
-32.6%
2,129,204
+0.4%
0.14%
-41.7%
Q4 2022$120,660
-99.9%
2,120,571
-1.3%
0.24%
+40.7%
Q3 2022$84,943,000
-11.1%
2,148,273
-1.1%
0.17%
-2.8%
Q2 2022$95,590,000
+9.7%
2,172,478
-0.6%
0.18%
+52.6%
Q1 2022$87,149,000
+12.4%
2,185,274
+13.4%
0.12%
+23.4%
Q4 2021$77,514,000
-3.3%
1,927,738
-2.1%
0.09%
-5.1%
Q3 2021$80,141,000
-10.6%
1,970,055
-0.3%
0.10%
-9.2%
Q2 2021$89,693,000
+8.6%
1,975,194
-0.3%
0.11%
+1.9%
Q1 2021$82,599,000
-2.6%
1,981,256
-0.2%
0.11%
-4.5%
Q4 2020$84,781,000
+123.0%
1,985,026
+37.2%
0.11%
+103.6%
Q3 2020$38,024,000
-0.1%
1,446,855
+1.9%
0.06%
-9.8%
Q2 2020$38,052,000
+63.2%
1,419,336
+9.5%
0.06%
+27.1%
Q1 2020$23,315,000
+2.1%
1,296,003
+0.6%
0.05%
+23.1%
Q4 2019$22,835,000
+13.9%
1,287,945
-0.3%
0.04%0.0%
Q3 2019$20,041,0001,292,1630.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders